TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,023 Cr | ₹2,585 Cr | ₹3,266 Cr | ₹2,368 Cr | ₹1,803 Cr |
What is the latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,023 Cr |
| Mar2025 | ₹2,585 Cr |
| Mar2024 | ₹3,266 Cr |
| Mar2023 | ₹2,368 Cr |
| Mar2022 | ₹1,803 Cr |
How is Cash Flow from Operating Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,023 Cr | 16.93 | |
| Mar2025 | ₹2,585 Cr | -20.85 | |
| Mar2024 | ₹3,266 Cr | 37.92 | |
| Mar2023 | ₹2,368 Cr | 31.34 | |
| Mar2022 | ₹1,803 Cr | - | |
Compare Cash Flow from Operating Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹179,470.8 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
| MANKIND PHARMA | ₹103,881.0 Cr | 1.1% | 1.2% | 3.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.8% |
-1.3% |
31.4% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses